Deep search
Web
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare targets 15 more drugs for price negotiations
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.
15h
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
15h
on MSN
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
15h
Ozempic, Wegovy among 15 drugs selected for next round of Medicare price negotiations
The price negotiations almost assures billions of dollars in savings for taxpayers.
Marketplace
17h
Both Democrats and Republicans largely support funding Medicaid and Medicare, poll finds
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
Modern Healthcare
23h
Medicare spending, insurance claim denials top concerns: KFF poll
Survey respondents pointed to federal health program spending, price transparency regulation and drug price negotiations as ...
1d
The Medicare maze: Finding providers in a shrinking network
It can be harder than ever for older Americans to find providers who accept Medicare at all, let alone those who are taking ...
1d
on MSN
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Joe Biden
Trump
Wegovy
Scott Bessent
Feedback